Free speech, PhRMA? Not in this off-label marketing case, feds say
This Fierce Pharma Marketing article discusses the debate surrounding off-label marketing as a free speech right. The DOJ has indicated that this should not be the case, in briefs filed in a whistleblower suit against Millenium Pharmaceuticals.
What are your thoughts on this issue?
This Fierce Pharma Marketing article discusses the debate surrounding off-label marketing as a free speech right. The DOJ has indicated that this should not be the case, in briefs filed in a whistleblower suit against Millenium Pharmaceuticals.
What are your thoughts on this issue?
Free speech, PhRMA? Not in this off-label marketing case, feds say
Aucun commentaire:
Enregistrer un commentaire